May 8th - $TELESIS BIO (TBIO.US)$ is about to implement a 1-for-18 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 9th, 2024.
$TELESIS BIO (TBIO.US)$ slipped 9.97% and closed at $0.306 on May 7th with a turnover of $241.45K. $TELESIS BIO (TBIO.US)$ now has a total market capitalization of $9.21 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.